The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Open accessPublished version of a preprint
Abstract
Significance: The rapid spread of the virus causing COVID-19, SARS-CoV-2, raises questions about the possibility of a universally effective vaccine. The virus can mutate in a given individual, and these variants can be propagated across populations and time. To understand this process, we analyze 18,514 SARS-CoV-2 sequences sampled since December 2019. We find that neutral evolution, rather than adaptive selection, can explain the rare mutations seen across SARS-CoV-2 genomes. In the immunogenic Spike protein, the D614G mutation has become consensus, yet there is no evidence of mutations affecting binding to the ACE2 receptor. Our results suggest that, to date, the limited diversity seen in SARS-CoV-2 should not preclude a single vaccine from providing global protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies
Nguyen, L.-T., Schmidt, H. A., von Haeseler, A., & Minh, B. Q. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msu300 · Cited by 26,046
ModelFinder: fast model selection for accurate phylogenetic estimates
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A., & Jermiin, L. S. (2017) · Nature Methods · doi:10.1038/nmeth.4285 · Cited by 18,449
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · cited 3×
“In the context of rare SARS-CoV-2 mutations, the rapid spread of the D614G mutation is singular and has led authors to hypothesize that viruses with D614G may have enhanced fitness (24).”
BackgroundResult
Research works printed but not linked: 44
- F. Wu . Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv:10.1101/2020.03.30.20047365 (20 April 2020). · DOI · Paper page
- 10.1016/j.celrep.2020.107725 · DOI · Paper page
- 10.1038/s41586-020-2012-7 · DOI · Paper page
- A. Latinne . Origin and cross-species transmission of bat coronaviruses in China. bioRxiv:10.1101/2020.05.31.116061 (31 May 2020). · DOI
- 10.1016/j.cub.2020.05.023 · DOI · Paper page
- 10.1038/s41586-020-2169-0 · DOI · Paper page
- 10.1038/s41586-020-2313-x · DOI · Paper page
- S. Duchene . Temporal signal and the phylodynamic threshold of SARS-CoV-2. bioRxiv:10.1101/2020.05.04.077735 (4 May 2020). · DOI
- 10.1038/nrg2323 · DOI · Paper page
- 10.1098/rspb.2014.0732 · DOI · Paper page
- 10.1038/nature13087 · DOI · Paper page
- 10.1016/j.cell.2015.07.020 · DOI · Paper page
- 10.1016/j.cell.2015.06.007 · DOI · Paper page
- M. Worobey . The emergence of SARS-CoV-2 in Europe and the US. bioRxiv:10.1101/2020.05.21.109322 (23 May 2020). · DOI
- L. Zhang . The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv:10.1101/2020.06.12.148726 (12 June 2020). · DOI
- S. Ozono . Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry. bioRxiv:10.1101/2020.06.15.151779 (26 June 2020). · DOI
- J. Hu . D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity. bioRxiv:10.1101/2020.06.20.161323 (6 July 2020). · DOI
- 10.1073/pnas.70.12.3321 · DOI · Paper page
- 10.1111/j.1365-294X.2008.03887.x · DOI · Paper page
- 10.1111/j.1755-0998.2012.03174.x · DOI · Paper page
- 10.7554/eLife.03568 · DOI · Paper page
- 10.1371/journal.pcbi.1004312 · DOI
- 10.1093/sysbio/syx046 · DOI
- 10.1093/sysbio/syv116 · DOI
- 10.1093/ve/vez044 · DOI
- 10.1126/science.1070441 · DOI · Paper page
- 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
- 10.1586/erv.09.43 · DOI · Paper page
- 10.1126/science.1256427 · DOI · Paper page
- 10.7554/eLife.49324 · DOI
- 10.1016/j.chom.2017.02.002 · DOI
- 10.1111/gtc.12463 · DOI
- 10.1128/JVI.01913-16 · DOI
- G. Wong ., Naturally occurring single mutations in Ebola virus observably impact infectivity. J. Virol. 93, e01098-18 (2018).
- 10.1016/j.celrep.2018.04.027 · DOI
- 10.1093/ve/vew007 · DOI · Paper page
- 10.1093/bioinformatics/bty633 · DOI · Paper page
- 10.1093/molbev/msy194 · DOI · Paper page
- 10.1093/molbev/msi105 · DOI · Paper page
- 10.1111/j.1365-294X.2010.04996.x · DOI · Paper page
- 10.1111/2041-210X.12526 · DOI · Paper page
- 10.1093/oxfordjournals.molbev.a026369 · DOI · Paper page
- 10.1093/nar/gkaa379 · DOI · Paper page
- 10.1111/tan.13811 · DOI · Paper page
Cited by
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
The biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
van Dorp, L., Acman, M., Richard, D., Shaw, L. P., Ford, C. E., Ormond, L., Owen, C. J., Pang, J., Tan, C. C. S., Boshier, F. A. T., et al. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104351 · Cited by 774
Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30773-8 · Cited by 633
Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.037 · Cited by 606
Looking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 585
SARS-CoV-2 within-host diversity and transmission
Lythgoe, K. A., Hall, M., Ferretti, L., de Cesare, M., MacIntyre-Cockett, G., Trebes, A., Andersson, M., Otecko, N., Wise, E. L., Moore, N., et al. (2021) · Science · doi:10.1126/science.abg0821 · Cited by 383
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
Martin, D. P., Weaver, S., Tegally, H., San, J. E., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.003 · Cited by 291
What reinfections mean for COVID-19
Iwasaki, A. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30783-0 · Cited by 230
Martin, D. P., Weaver, S., Tegally, H., San, E. J., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · doi:10.1101/2021.02.23.21252268 · Cited by 291
“Besides immune evasion, other plausible contributors to the fitness advantage of viruses in the 501Y lineages are: (1) that they produce more particles at anatomical sites suitable for optimal droplet or aerosol transmission, (2) that they produce particles that individually have physical properties that increase thei…”
BackgroundCoincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria
Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Zayas, J., Bhimalli, P. P., Ash, M. K., et al. (2021) · doi:10.1101/2021.04.09.21255206 · Cited by 34
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose
Nag, K., Chandra Baray, J., Rahman Khan, M., Mahmud, A., Islam, J., Myti, S., Ali, R., Haq Sarker, E., Kumar, S., Hossain Chowdhury, M., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.035 · Cited by 13
Metadata
- Authors
- Dearlove, B., Lewitus, E., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., Modjarrad, K., & Rolland, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2020-08-31
- Volume
- 117
- Issue
- 38
- Pages
- 23652-23662
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3082387069
- Cited by
- 200
- References
- 22
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.